The Stress Hyperglycemia Ratio is Associated with Hemorrhagic Transformation in Patients with Acute Ischemic Stroke

References

• Alvarez-Sabin J, Maisterra O, Santamarina E, Kase CS. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol. 2013;12(7):689–705. doi:10.1016/S1474-4422(13)70055-323726850
   PubMed Web of Science ®Google Scholar
• Moulin T, Crepin-Leblond T, Chopard JL, Bogousslavsky J. Hemorrhagic infarcts. Eur Neurol. 1994;34(2):64–77. doi:10.1159/0001170128174597
   PubMed Web of Science ®Google Scholar
• Fagan SC, Lapchak PA, Liebeskind DS, Ishrat T, Ergul A. Recommendations for preclinical research in hemorrhagic transformation. Transl Stroke Res. 2013;4(3):322–327. doi:10.1007/s12975-012-0222-523730351
   PubMed Web of Science ®Google Scholar
• Park JH, Ko Y, Kim WJ, et al. Is asymptomatic hemorrhagic transformation really innocuous? Neurology. 2012;78(6):421–426. doi:10.1212/WNL.0b013e318245d22c22282643
   PubMed Web of Science ®Google Scholar
• Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(12):e343–e361. doi:10.1161/STR.000000000000015229097489
   PubMed Web of Science ®Google Scholar
• Kaesmacher J, Kaesmacher M, Maegerlein C, et al. Hemorrhagic transformations after thrombectomy: risk factors and clinical relevance. Cerebrovasc Dis. 2017;43(5–6):294–304. doi:10.1159/00046026528343220
   PubMed Web of Science ®Google Scholar
• Okada Y, Yamaguchi T, Minematsu K, et al. Hemorrhagic transformation in cerebral embolism. Stroke. 1989;20(5):598–603. doi:10.1161/01.STR.20.5.5982718199
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Gupta R, Jovin TG, et al. Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients. J Neurointerv Surg. 2015;7(1):16–21. doi:10.1136/neurintsurg-2013-01074324401478
   PubMed Web of Science ®Google Scholar
• Butcher K, Christensen S, Parsons M, et al. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010;41(1):72–77. doi:10.1161/STROKEAHA.109.56376719926841
   PubMed Web of Science ®Google Scholar
• Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32(2):438–441. doi:10.1161/01.STR.32.2.43811157179
   PubMed Web of Science ®Google Scholar
• Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology. 2001;57(9):1603–1610. doi:10.1212/WNL.57.9.160311706099
   PubMed Web of Science ®Google Scholar
• National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–1587. doi:10.1056/NEJM1995121433324017477192
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Mavridis D, et al. Association of baseline hyperglycemia with outcomes of patients with and without diabetes with acute ischemic stroke treated with intravenous thrombolysis: a propensity score-matched analysis from the SITS-ISTR registry. Diabetes. 2019;68(9):1861–1869. doi:10.2337/db19-044031217175
   PubMed Web of Science ®Google Scholar
• Palaiodimou L, Lioutas VA, Lambadiari V, Paraskevas GP, Voumvourakis K, Tsivgoulis G. Glycemia management in acute ischemic stroke: current concepts and novel therapeutic targets. Postgrad Med. 2019;131(7):423–437. doi:10.1080/00325481.2019.165120631382796
   PubMed Web of Science ®Google Scholar
• Arcambal A, Taile J, Rondeau P, Viranaicken W, Meilhac O, Gonthier MP. Hyperglycemia modulates redox, inflammatory and vasoactive markers through specific signaling pathways in cerebral endothelial cells: insights on insulin protective action. Free Radic Biol Med. 2019;130:59–70. doi:10.1016/j.freeradbiomed.2018.10.43030359759
   PubMed Web of Science ®Google Scholar
• Rom S, Zuluaga-Ramirez V, Gajghate S, et al. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both Diabetes Mellitus (DM) type 1 and type 2 mouse models. Mol Neurobiol. 2019;56(3):1883–1896. doi:10.1007/s12035-018-1195-529974394
   PubMed Web of Science ®Google Scholar
• Kim JS. tPA helpers in the treatment of acute ischemic stroke: are they ready for clinical use? J Stroke. 2019;21(2):160–174. doi:10.5853/jos.2019.0058431161761
   PubMed Web of Science ®Google Scholar
• Rodríguez-Yáñez M, Castellanos M, Blanco M, et al. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology. 2006;67(7):1172–1177. doi:10.1212/01.wnl.0000238353.89194.0817030748
   PubMed Web of Science ®Google Scholar
• Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426–2432. doi:10.1161/hs1001.09619411588337
   PubMed Web of Science ®Google Scholar
• Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798–1807. doi:10.1016/S0140-6736(09)60553-519465235
   PubMed Web of Science ®Google Scholar
• Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–591. doi:10.2337/diacare.27.2.55314747243
   PubMed Web of Science ®Google Scholar
• Zonneveld TP, Nederkoorn PJ, Westendorp WF, Brouwer MC, van de Beek D, Kruyt ND. Hyperglycemia predicts poststroke infections in acute ischemic stroke. Neurology. 2017;88(15):1415–1421. doi:10.1212/WNL.000000000000381128283600
   PubMed Web of Science ®Google Scholar
• Welsh C, Welsh P, Celis-Morales CA, et al. Glycated hemoglobin, prediabetes, and the links to cardiovascular disease: data from UK biobank. Diabetes Care. 2020;43(2):440–445. doi:10.2337/dc19-168331852727
   PubMed Web of Science ®Google Scholar
• Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Ther. 2019;10(3):853–863. doi:10.1007/s13300-019-0619-131037553
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–S27. doi:10.2337/dc18-S00229222373
   PubMed Web of Science ®Google Scholar
• Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.357678184
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 1997;28(2):307–310. doi:10.1161/01.STR.28.2.3079040680
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study investigators. Lancet. 1998;352(9136):1245–1251. doi:10.1016/s0140-6736(98)08020-99788453
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Agnelli G, Corea F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke. 2008;39(8):2249–2256. doi:10.1161/STROKEAHA.107.51032118535273
   PubMed Web of Science ®Google Scholar
• Roberts GW, Quinn SJ, Valentine N, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490–4497. doi:10.1210/jc.2015-266026485219
   PubMed Web of Science ®Google Scholar
• Su YW, Hsu CY, Guo YW, Chen HS. Usefulness of the plasma glucose concentration-to-HbA(1c) ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. Diabetes Metab. 2017;43(1):40–47. doi:10.1016/j.diabet.2016.07.03627663631
   PubMed Web of Science ®Google Scholar
• Yang Y, Kim TH, Yoon KH, et al. The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention. Int J Cardiol. 2017;241:57–63. doi:10.1016/j.ijcard.2017.02.06528256326
   PubMed Web of Science ®Google Scholar
• Pan Y, Cai X, Jing J, et al. Stress hyperglycemia and prognosis of minor ischemic stroke and transient ischemic attack: the CHANCE study (clopidogrel in high-risk patients with acute nondisabling cerebrovascular events). Stroke. 2017;48(11):3006–3011. doi:10.1161/STROKEAHA.117.01908129051218
   PubMed Web of Science ®Google Scholar
• Adams HP, Del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115(20):e478–e534. doi:10.1161/CIRCULATIONAHA.107.18148617515473
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu N, Han J, et al. Diabetes mellitus/poststroke hyperglycemia: a detrimental factor for tPA thrombolytic stroke therapy. Transl Stroke Res. 2020. doi:10.1007/s12975-020-00872-3
   Web of Science ®Google Scholar
• Zhou Y, Zhang X, Zhang L, et al. Increased stroke risk in metabolically abnormal normal weight: a 10-year follow-up of 102,037 participants in China. Transl Stroke Res. 2020. doi:10.1007/s12975-020-00866-1
   Web of Science ®Google Scholar
• Pol T, Held C, Westerbergh J, et al. Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with oral anticoagulation therapy: insights from the ARISTOTLE (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation) trial. J Am Heart Assoc. 2018;7(3). doi:10.1161/JAHA.117.007444.
   Web of Science ®Google Scholar
• Baird TA, Parsons MW, Phan T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34(9):2208–2214. doi:10.1161/01.STR.0000085087.41330.FF12893952
   PubMed Web of Science ®Google Scholar
• Huang ZX, Huang Y, Zeng J, et al. Admission glucose levels may increase the risk for early neurological deterioration in females with acute ischemic stroke. Front Neurol. 2020;11:548892. doi:10.3389/fneur.2020.54889233250841
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang R, Song B, et al. Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke. Int J Stroke. 2015;10(5):752–758. doi:10.1111/ijs.1247125924059
   PubMed Web of Science ®Google Scholar
• Byun YS, Yang X, Bao W, et al. Oxidized phospholipids on apolipoprotein B-100 and recurrent ischemic events following stroke or transient ischemic attack. J Am Coll Cardiol. 2017;69(2):147–158. doi:10.1016/j.jacc.2016.10.05728081824
   PubMed Web of Science ®Google Scholar
• Lee JS, Chang PY, Zhang Y, Kizer JR, Best LG, Howard BV. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study. Diabetes Care. 2017;40(4):529–537. doi:10.2337/dc16-195828122840
   PubMed Web of Science ®Google Scholar
• Yoon JA, Kim DY, Sohn MK, et al. Effect of stress hyperglycemia and intensive rehabilitation therapy in non-diabetic hemorrhagic stroke: Korean stroke cohort for functioning and rehabilitation. Eur J Neurol. 2016;23(11):1658–1665. doi:10.1111/ene.1310127444813
   PubMed Web of Science ®Google Scholar
• Tziomalos K, Dimitriou P, Bouziana SD, et al. Stress hyperglycemia and acute ischemic stroke in-hospital outcome. Metabolism. 2017;67:99–105. doi:10.1016/j.metabol.2016.11.01128081783
   PubMed Web of Science ®Google Scholar
• Marfella R, Siniscalchi M, Esposito K, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care. 2003;26(11):3129–3135. doi:10.2337/diacare.26.11.312914578250
   PubMed Web of Science ®Google Scholar
• Ergul A, Abdelsaid M, Fouda AY, Fagan SC. Cerebral neovascularization in diabetes: implications for stroke recovery and beyond. J Cereb Blood Flow Metab. 2014;34(4):553–563. doi:10.1038/jcbfm.2014.1824496174
   PubMed Web of Science ®Google Scholar
• Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23(5):599–622.12372842
   PubMed Web of Science ®Google Scholar
• Won SJ, Tang XN, Suh SW, Yenari MA, Swanson RA. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production. Ann Neurol. 2011;70(4):583–590. doi:10.1002/ana.2253822002675
   PubMed Web of Science ®Google Scholar
• Wang X, Tsuji K, Lee SR, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35(11 Suppl 1):2726–2730. doi:10.1161/01.STR.0000143219.16695.af15459442
   PubMed Web of Science ®Google Scholar
• Khatri R, McKinney AM, Swenson B, Janardhan V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012;79(13 Suppl 1):S52–S57. doi:10.1212/WNL.0b013e3182697e7023008413
   PubMed Web of Science ®Google Scholar
• Worthley MI, Holmes AS, Willoughby SR, et al. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol. 2007;49(3):304–310. doi:10.1016/j.jacc.2006.08.05317239711
   PubMed Web of Science ®Google Scholar